Topical composition with active compounds from
Disclosed is a topical composition including essential combination of synergistically acting phyto-active materials, non-psychotropic phytocannabinoids from the plant of Cannabis sativa : Cannabidiol, Cannabidiolic acid, Cannabivarin Cannabigerol in combination with extract of Calendula flower and the formulation of the base to ensure the features of anti-inflammation, anti-oxidation, emollient, and bactericidal components. The topical composition is an emollient dedicated for reduction of skin lesions caused by atopic dermatitis, urticaria, radiotherapy and UV induced skin damage and acne. In addition the topical composition could reduce secretion of fats, facilitate deep skin hydration, reduce pores and exert soothing effect.
1. A topical composition comprising: about 8.76% Caprylic/capric triglyceride, 5.64% Aloe barbadensis leaf juice, 0.94% Stearic acid, 0.52% Glycerol monostearate, 0.25% Trietanolamine, 0.4% Vitamin E, 3.33% Olive europaea Fruit Oil, 3.33% Glycerol, 0.6% Acrylates/C10-30 alkyl acrylate crosspolymer, 0.07% Calendula Officinalis Flower Extract, 0.8% Phenoxyethanol, and water,
wherein the composition further comprises 0.75-1% of a Cannabis sativa extract in decarboxylated form and containing 0.25% of CBD, and 0.75-1% of the Cannabis sativa extract in non-carboxylated form and containing 0.25% CBDA, wherein the Cannabis sativa extract comprises about 80% of CBDA from the total cannabinoids, and THC is less than 0.1%.
2. A topical composition according to claim 1 , wherein the Cannabis sativa extract is made from any non-psychotropic Cannabis sativa variety.
3. The topical composition according to claim 2 , wherein the Cannabis sativa extract is made from the Benico variety.
4. A topical composition according to claim 1 with a dynamic viscosity from 2100 to 2300 mPa and a pH of about 6.